Coherus Oncology, Inc. Common Stock
CHRS
CHRS
115 hedge funds and large institutions have $867M invested in Coherus Oncology, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+12
Holders Change %
+11.65%
% of All Funds
2.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
48
Reduced
25
Closed
15
Calls
$14.6M
Puts
$9.23M
Net Calls
+$5.4M
Net Calls Change
+$4.38M
Top Buyers
1 |
FCM
Farallon Capital Management
San Francisco,
California
|
$11.8M |
2 |
BlackRock
New York
|
$58M |
3 |
HP
Hound Partners
New York
|
$10.9M |
4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$18.4M |
5 |
MWNA
Marshall Wace North America
New York
|
$8.96M |